The tranexamic acid “could avoid” deaths by bleeding in patients with trauma

2011, Number 4

Rev Cub Med Int Emerg 2011; 10 (4)

Iraola FMD, Marrero MMA

Language: Spanish
References: 3
Page: 2305-2306
PDF size: 128.83 Kb.

Text Extraction

No abstract.

REFERENCES

CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376(9734): 23-32
CRASH-2 trial collaborators. The importance of early treatment with tranexamic acid in bleending trauma patients, on exploratory analysis of the CRASH 2 randomised controlled trial. Lancet 2011; 377(9771): 1096-101. Newletter. Edición 16–junio 2010. Disponible en: http://www.crash2.lshtm.ac.uk/Spanish/index.php [Consultado: 29 de noviembre 2011].
Iraola MD. Calidad en Medicina de Emergencia. Electron J Biomed 2004; 2(1): 24-39. Disponible en: http://biomed.uninet.edu/2004/n1/mif.pdf [Consultado: 29 de noviembre 2011].